Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating how ropinirole is absorbed, distributed, metabolized and excreted, and how food affects its pharmacokinetics in restless legs sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Phase 1 | Status: COMPLETED